Data governance and GDPR for Marburg organisations: controls that produce evidence

The question that exposes an analytics estate is simple: who could see this dataset last quarter? In most organisations the honest answer takes a week of investigation.

This page covers data governance and compliance for analytics estates in Marburg: what the federal commissioner (BfDI) and the Land data protection authorities expects under the EU GDPR and the Bundesdatenschutzgesetz (BDSG), which sector rules bite hardest given the local economy of pharmaceuticals and biotech, higher education and research, and healthcare provision, and how to implement controls in Microsoft Purview and Power BI that produce evidence rather than paperwork.

What the federal commissioner (BfDI) and the Land data protection authorities expects of an analytics estate

Under the EU GDPR and the Bundesdatenschutzgesetz (BDSG), the obligations that touch analytics most directly are data minimisation, storage limitation, access control, and the ability to answer access and erasure requests. Analytics estates fail these quietly: a warehouse accumulates every column from every source because it was easier than deciding, retention defaults to forever, and permissions are granted to individuals who then change role.

• Betriebsrat co-determination is the single most underestimated factor in German analytics projects: any reporting that could be used to assess individual employee performance generally needs a works agreement before launch.
• MaRisk and BAIT expectations mean financial-sector data lineage and documentation standards are explicit, not inferred.
• The Lieferkettensorgfaltspflichtengesetz requires supply-chain due-diligence data that most ERP estates do not hold in reportable form.
• GoBD rules on retention and immutability of accounting-relevant data affect how analytics copies of financial data are stored.

None of this requires a governance department. It requires four things that can be implemented in weeks: a catalogue people actually search, classification that drives retention and labelling, access granted through groups, and evidence that can be produced without a project.

Sector rules that bite in Marburg

Marburg's economy means the governance conversation here is not generic. With vaccine and biologics manufacturing and a research university with strong pharmacy and medicine shaping the local client base, these are the obligations that come up in practice.

Pharmaceuticals and biotech

GxP data integrity expectations (attributable, legible, contemporaneous, original, accurate) apply to analytics pipelines handling regulated data. Regulated data across research, clinical, manufacturing and commercial domains, with validation requirements that make casual changes to a pipeline expensive.

The practical consequence for an analytics estate is that access design cannot be retrofitted. Row-level and object-level security have to reflect how authority is actually delegated in the organisation, and the design needs testing from a non-privileged account rather than assumed from documentation.

Medical devices

EU MDR post-market surveillance and vigilance reporting require a reproducible data trail from field event back to production batch. Typical systems in scope: ERP, QMS, complaint handling systems, PLM and distributor reporting.

Higher education and research

Student data is personal data with additional duties around special-category attributes, and research data may carry funder-specific restrictions.

Who can see what, and how you prove it

This is the question that exposes an estate, and the fix is unglamorous. Permissions granted to individuals over several years cannot be evidenced without manual investigation. Permissions granted to directory groups that mirror your control model can be reported on in minutes.

The sequence is always the same: extract the permissions that actually exist, design groups around how the organisation really delegates authority, migrate and remove the individual grants, then make the evidence self-service so your second line runs the report instead of raising a request. For a business in pharmaceuticals and biotech, the groups normally need granularity by function and by entity or site.

Classification, labels and the export problem

The leak is usually an export, not an attack. Someone needed the figures in a spreadsheet to do their job, and the spreadsheet then went somewhere nobody tracked. Sensitivity labels applied in Power BI travel with the exported file, so encryption and access restrictions persist outside the platform, and export can be blocked entirely for specific labels or audiences.

The classification scheme has to align to the information security policy you already have rather than introduce a competing taxonomy, and retention has to be enforced against your actual obligation under the EU GDPR and the Bundesdatenschutzgesetz (BDSG) instead of kept forever by default. Every control is then verified from a non-privileged account, because the most common finding in a governance review is a restriction that was configured correctly and never actually tried.

Working with German organisations: the practical constraints

• Specification discipline is higher than in the UK: expect a written Fachkonzept and a documented acceptance process, and plan for it rather than resisting it.
• Works council consultation should be scheduled at the start of a project, not discovered during user acceptance testing.
• Many Mittelstand clients prefer German-language documentation and stakeholder sessions even where the project team works in English.

The most underestimated factor in German governance projects is works council co-determination. Any reporting that could be used to assess individual employee performance generally needs a works agreement before launch, and discovering that during user acceptance testing is expensive. We schedule that consultation at the start.

A 90-day plan that produces evidence

1. Days 1 to 15: assessAccess extract versus policy, data map, classification gaps, retention reality. Output is a risk-ranked remediation plan, ordered by exposure rather than by ease.
2. Days 15 to 35: defineOwnership assigned to named people, classification agreed, retention written against the real obligation, access standards set. None of it drafted in isolation from legal or the business.
3. Days 35 to 70: implementPurview scanning and catalogue populated, labels published and applied, access rebuilt onto groups, lineage switched on, suppression implemented in measures.
4. Days 70 to 90: evidenceAccess evidence reporting, audit pack generation, steward training, and the first governance review run with your team rather than for them.

That sequence works because each stage produces something usable on its own. If the programme stops after the assessment, you still hold a risk-ranked plan an auditor would accept. Book a technical review if you want that assessment for a Marburg organisation.

We work across Germany and deliver into neighbouring markets regularly. Nearby pages worth reading if your group has sites elsewhere: Heidelberg, Tübingen, Münster, Mainz, Würzburg and Göttingen.

Frequently asked questions